PedAM
Pediatric Disease Annotations & Medicines
| Disease | heart disease |
| Phenotype | C0024115|lung disease |
| Sentences | 7 |
| PubMedID- 20216166 | Further investigation is warranted in selected populations, such as the growing group of children with congenital heart disease complicated by chronic lung disease of prematurity, and in the developing world where patients may be more likely to present late with advanced pulmonary vascular disease. |
| PubMedID- 20814479 | A hybrid approach without the use of cpb should be considered in the management of infants with congenital heart disease, associated with chronic lung disease and pulmonary hypertension. |
| PubMedID- 24763387 | Palivizumab is administered prophylactically to high-risk infants, such as those with chronic lung disease of prematurity, congenital heart disease, or premature birth at less than 36 weeks gestational age, but it costs $4,500 per patient treatment course [5]. |
| PubMedID- 24551834 | Groups ii–v are categorized as ph associated left heart disease, ph associated with lung diseases/hypoxia, ph due to embolic and/or chronic thrombotic disease, and ph associated with miscellaneous conditions, respectively. |
| PubMedID- 21695173 | Ph is caused by a variety of diseases including pulmonary arterial hypertension (pah), ph secondary to left-sided heart disease, ph associated with lung disease and/or hypoxia, and ph resulting from chronic thrombotic/embolic disease [1]. |
| PubMedID- 21829410 | Chronic lung disease, prematurity, along with congenital heart disease (chd) are major risk factors in severe lower respiratory infection. |
| PubMedID- 21910858 | High-risk groups for severe rsv infection include infants with preterm birth, chronic lung disease of prematurity, congenital heart disease, cystic fibrosis, immunodeficiency disorders, and down's syndrome [5,6]. |
Page: 1